Statistical analysis plan for the Diagnosing deep-vein Thrombosis early in critically ill patients (DETECT) trial: a study protocol for a randomized controlled trial
Year: 2026
Type: article
Study design: Study Protocol
Abstract: Background Deep vein thrombosis (DVT) in critically ill patients is often undetected and could lead to pulmonary embolism (PE) and subsequent morbidity and mortality. Ultrasound surveillance for DVT may facilitate early detection and treatment of DVTs in high-risk medical-surgical ICU patients and thus may improve patient outcomes. Objective The Diagnosing deep-vein thrombosis early in critically ill patients (DETECT) trial aims to evaluate the effect of twice-weekly surveillance bilateral lower limb ultrasound compared to usual care on 90-day mortality of critically ill adults admitted to medical, surgical, and trauma ICUs. Methods/Design In this multicenter randomized trial, critically ill patients will be randomized to twice-weekly surveillance bilateral lower limb ultrasound (surveillance group) or usual care group. The primary outcome is 90-day mortality. The trial has 80% power to detect a 6% absolute risk reduction in 90-day mortality from 30 to 24%. Secondary outcomes include lower limb proximal DVT, pulmonary embolism and clinically important bleeding. Results As of May 31, 2026 a total of 1721 patients have been recruited from 15 centers across Saudi Arabia and Kuwait. Discussion This statistical analysis plan for the DETECT Trial was developed following international guidelines. This plan specifies a priori the statistical methods for evaluating primary and secondary outcomes and defines covariables for adjusted analyses. Trial registration Clinicaltrials.gov NCT05112705 (registered on 2021-10-26 and posted on 2021-11-09 after quality check).
Source: F1000Research
Authors: Yaseen M. Arabi, Farhan Alenezi, Fahad Al-Hameed, Haifaa Ibrahim AlHumedi, Ayman Kharaba, Waleed Alhazzani, Mohammed S. Alshahrani, Haifa Algethamy, Khalid Maghrabi, Jamal Chalabi, Husam I. Ardah, Jesna Jose, Ali Mousa Alahmari, Rakan M. AlQahtani, Abdalmohsen A. Ababtain, Wafa Mansoor, Abdulrahman A Al-Fares, Sarah Fadel Buabbas, Felwa bin Humaid, Mohammed J. Brembali,, Gulam Rasool Ahmed, Ghassan Almazyad, Ahmad Al Khalaf, Marwa Amer, Musharaf Sadat, Shaya Yaanallah AlQahtani, Osama Ahmed Elfaki, Abdullah Al Tamimi, Amjad AlHumaidan, Mohammed Alqahtani, Abdulaziz Al-Dawood, Saudi Critical Care Trials Group
Institutions: King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, National Guard Health Affairs, Ministry of Defense, Research and Innovation Institute, King Fahd Hospital of the University, Imam Abdulrahman Bin Faisal University, King Abdulaziz University, King Abdul Aziz University Hospital, King Abdulaziz Hospital, King Abdulaziz Hospital, King Faisal Specialist Hospital & Research Centre, Armed Forces Hospital Southern Region, King Saud University, Prince Mohammed bin Abdulaziz Hospital, Amiri Hospital, Ministry of Health, Al-Sabah Hospital, Alfaisal University, Riyadh Armed Forces Hospital
Language: English
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,350
Awards: G7790243191, G9001374585
OpenAlex ID: W7161759313
